SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001052918-18-000227
Filing Date
2018-06-19
Accepted
2018-06-18 18:59:23
Documents
124
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 VANC PHARMACEUTICALS INC. FORM 20F-A vanc20fjun15-18final.htm 20-F/A 1161950
2 CERTIFICATION ceocertification302.htm EX-12 8511
3 CERTIFICATION cfocertification302.htm EX-12 8474
4 CERTIFICATION ceocertification906.htm EX-13 3104
5 CERTIFICATION cfocertification906.htm EX-13 3019
6 AUDITOR LETTER ex15-1.htm EX-15 2580
7 AUDITOR LETTER ex15-2.htm EX-15 2411
8 ex1512.gif GRAPHIC 217099
9 ex1522.gif GRAPHIC 28203
10 ex1524.gif GRAPHIC 16574
11 vanc20fjun1518final1.jpg GRAPHIC 50782
12 vanc20fjun1518final3.gif GRAPHIC 135361
13 vanc20fjun1518final5.gif GRAPHIC 116415
14 vanc20fjun1518final9.gif GRAPHIC 29317
15 vanc20fjun1518final11.gif GRAPHIC 18280
16 vanc20fjun1518final7.gif GRAPHIC 217099
  Complete submission text file 0001052918-18-000227.txt   6080269

Data Files

Seq Description Document Type Size
17 vanc-20171231.xml EX-101.INS 982530
18 vanc-20171231.xsd EX-101.SCH 83658
19 vanc-20171231_cal.xml EX-101.CAL 49383
20 vanc-20171231_def.xml EX-101.DEF 138476
21 vanc-20171231_lab.xml EX-101.LAB 275906
22 vanc-20171231_pre.xml EX-101.PRE 268079
Mailing Address 789 WEST PENDER STREET SUITE 1128 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 1128 VANCOUVER A1 V6C 1H2 604-687-2038
Vanc Pharmaceuticals Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 000-51848 | Film No.: 18905764
SIC: 2834 Pharmaceutical Preparations